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Background and Study Aims: Early diagnosis of small-bowel tumors is crucial for therapy. Video capsule 
endoscopy has improved the diagnosis of small-bowel diseases, but data concerning the role of this technique in 
detecting small-bowel malignancy are scarce. The aim of this paper was to review all capsule endoscopy 
findings at Belgian hospitals, in order to evaluate the diagnostic yield of capsule endoscopy in the field of small-
bowel malignancy. 
Patients and Methods: For this retrospective study, the seven Belgian academic hospitals where the device was 
being used were asked to review the findings obtained by means of video capsule endoscopy, and to collect 
information about the cases of small-bowel malignancy. 
Results: In total, 443 capsule endoscopies were performed up to November 2004, and 11 malignant small-bowel 
processes were detected (2.5%). The most frequent indications for performing capsule endoscopy in those 11 
cases were intestinal bleeding of undefined origin or iron-deficiency anemia. The mean number of diagnostic 
procedures performed before capsule endoscopy was 3.6. The capsule endoscopy results had a diagnostic yield 
of 1.6% after classical work-up. In 55% of these cases, capsule endoscopy findings had an influence on therapy.  
Conclusions: Tumors of the small bowel remain a rare condition. Video capsule endoscopy is able to detect 
tumors undiagnosed by classical procedures in about 1.6% of cases and has an impact on the therapy in 55 % of 
the tumor cases. 
 
Introduction 
Diagnosis of small-bowel disease is difficult due to the partial inaccessibility of this organ to endoscopy. In 
particular, vascular lesions escape the traditional work-up using small-bowel series. Video capsule endoscopy 
was devised to improve the diagnosis of small-bowel diseases. The M2A video capsule endoscope (Given 
Imaging, Yoqneam, Israel), a wireless capsule 27 mm × 11 mm in size, has been available for clinical purposes 
for 3 years. 
A range of indications became apparent with time, especially in the field of bleeding of undefined etiology. For 
this indication, capsule endoscopy provides an added diagnostic yield superior to that of push enteroscopy, i.e., 
of 50%-67% versus 25%-30% [1,2]. Different authors have also demonstrated the superiority of capsule 
endoscopy compared with small-bowel radiography [3] or entero-computed tomography (CT) [4]. Other 
indications for capsule endoscopy are Crohn's disease, nonsteroidal anti-inflammatory drug (NSAID)-induced 
small-bowel damage, celiac disease and chronic diarrhea. Data on the ability of capsule endoscopy to detect 
small-bowel tumors are, however, scarce, and the value of capsule endoscopy for detecting tumors is still being 
debated [5,6]. 
Patients and Methods 
The results of capsule endoscopy procedures up to November 2004 were retrospectively reviewed in the seven 
Belgian academic hospitals where capsule endoscopy is carried out. Only malignant small-bowel tumors were 
taken into account. The following information was gathered from the patient files: age, sex, indication for 
performing capsule endoscopy, diagnostic procedures (endoscopies, small-bowel radiographs, CT scan) 
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undergone before performance of capsule endoscopy, description and estimated location of the tumor, final 
diagnosis, and impact of capsule endoscopy findings on the management of the patient. The final diagnosis was 
obtained by histological examination of biopsy specimens or of surgical resection pieces. 
For all capsule endoscopy procedures, the M2A video capsule endoscope was used. At each center, patients 
fasted for 8 -10 hours before the procedure. At two centers, polyethylene glycol was used the day before the 
examination. No medications were used during the capsule endoscopy. Reading times at the centers varied 
between 40 and 90 minutes. 
Results 
In total, 443 capsule endoscopies were performed at the seven centers, and from these 443 procedures, 11 
malignant processes of the small bowel were identified (2.5%). These were found in six women and five men, 
whose mean age was 63.4 years (55-76). 
The indications for performing capsule endoscopy in these patients had been:  
-   intestinal bleeding of unidentified origin and iron-deficiency  anemia, n = 7; 
-   protein-losing enteropathy (PLE) and malabsorption, n = 2 ; 
-   episode of intestinal occlusion with spontaneous resolution, n = 1; and   
-   abdominal lymph nodes detected on CT scan, n = 1.  
The details for these patients (age, sex, indication, histological findings, location of malignancy, endoscopic 
appearance, and type of treatment) are presented in Table 1. 
 
Table 1.    Details of the patients with small-bowel malignancy 
Patient no., 
sex, age 
Indication Histology Location of 
malignancy 
Appearance Treatment applied 




Bleeding tumor Surgery 
2, M, 67 Episode of 
intestinal 
occlusion 










Stenosing mass Surgery and 
chemotherapy 
4, M, 55 Lymph nodes on 
CTscan 
Low grade T-cell 
lymphoma (diagnosis by 
lymph node biopsy) 
Jejunoileal Erosions, ulcers Chemotherapy 
5, F, 60 Malabsorption 
Protein-losing 
enteropathy 
T-cell lymphoma (Figure 
1) (biopsy obtained during 
push enteroscopy) 
Jejunoileal Deep ulcers 
Bleeding 
Chemotherapy 
6, M, 64 Unidentified 
intestinal bleeding 
Hemangiopericytoma Ileal Vascular tumor Surgery 
7, F, 64 Iron-deficiency 
anemia 
GIST tumor, c-kit+ Jejunum Ulceration, 
bleeding 
Surgery 
8, F, 66 Unidentified 
intestinal bleeding 
GIST tumor, c-kit+ Jejunum Irregular erosive 
bleeding lesion 
Surgery 
9, M, 57 Iron-deficiency 
anemia 
Adenocarcinoma Jejunum Bleeding ulcer Surgery and 
chemotherapy 
10, F, 57 Malabsorption 
Protein-losing 
enteropathy 




11, F, 74 Iron-deficiency 
anemia 




GIST, gastrointestinal stromal. 
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Figure 1.  Large deep ulcer in the jejunum, surrounded by cracked mucosa. A biopsy obtained by push 
enteroscopy showed an intestinal T-cell lymphoma. 
 
 
These patients had undergone a mean of 3.6 gastrointestinal diagnostic procedures before capsule endoscopy was 
performed. Some of these procedures had been done several times, and comprised: 
esophagogastroduodenoscopy, n = 13; colonoscopy, n = 11; small-bowel radiography, n = 8; CT scan, n = 4; and 
push enteroscopy, n = 4. 
The tumors were located in the jejunum in five patients, in the ileum in two patients, or were diffuse/multifocal 
(in four patients). 
The endoscopic appearances of the lesions on capsule endoscopy were of erosive or ulcerative lesions in six 
patients, and of a tumoral lesion in five. In five cases, active bleeding was detected. A stenosing mass was 
present in one patient, but there were no problems in passage of the capsule. 
There were, in total, four adenocarcinomas, three T-cell lymphomas, two gastrointestinal stromal (GIST) tumors, 
one case of multiple carcinoid tumors, and one hemangiopericytoma. 
Table 2 shows the impact of capsule endoscopy on diagnosis and therapy in these 11 patients. In 10/11 patients, 
capsule endoscopy was considered to have had an influence on the diagnosis. In three of these ten patients, 
however, capsule endoscopy confirmed lesions already detected by other diagnostic procedures (patients 5, 6, 
and 10), so that capsule endoscopy findings had an actual impact on diagnosis in 7/11 patients (64%). The 
diagnostic yield after performing a classical work-up in the entire studied population (443 procedures) is 
therefore 1.6%. In 6/11 patients (55%), capsule endoscopy had an impact on therapy. 
 
Table 2.  Influence of capsule endoscopy on diagnosis and therapy (+ some influence; - no influence) 
Patient no. Influence on diagnosis Influence on therapy 
1 (+) (+) 
2 (-)The lesions had already been identified on a small-bowel series (-) 
3 (+) (+) 
4 (+) Lymph nodes were detected by CT scan, capsule endoscopy pointed 
towards the diagnosis of intestinal lymphoma, but the diagnosis was 
established by lymph node biopsy 
(-) 
5 (+) Allowed definition of the extent of lesions detected by push-
enteroscopy 
(-) 
6 (+) Identified the intraluminal presence of a tumor detected by CT scan (-) 
7 (+) (+) 
8 (+) Tumor was also be detected by CTscan performed after capsule 
endoscopy 
(+) 
9 (+) (+) 
10 (+) Allowed definition of the extent of a process identified by push-
enteroscopy 
(-) 
11 (+) (+) 
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Discussion 
Evaluation of small-bowel disease by conventional endoscopy remains difficult. Push-enteroscopy allows 
visualization of 60-120 cm of the ligament of Treitz [3]. Routine retrograde ileoscopy is not always easy to 
perform and is limited to 10-60 cm of terminal ileum [7]. Small-bowel radiographs are able to provide correct 
images of this organ, but do not detect vascular abnormalities. Moreover, the best technique is enteroclysis [8], 
which is quite uncomfortable for the patient, is time-consuming, and has to be performed by skilled radiologists. 
CT and magnetic resonance imaging (MRI) enteroclysis are not widely available. 
Capsule endoscopy is an attractive technique developed by Given Imaging and has been available for clinical 
purposes for about 3 years. The increasing number of publications on capsule endoscopy underlines the interest 
of gastroenterologists in this comfortable, safe, and efficient technology. Bleedings of undefined origin, as well 
as Crohn's disease, are probably the main field of application of capsule endoscopy. On the other hand, data 
concerning the role of capsule endoscopy in detecting small-bowel tumors, and especially malignant ones, are 
scarce. De Mascarenhas-Saraiva et al. recently published a small series [9]. De Franchis et al. made an important 
review of small-bowel malignancy by collecting abstracts and studies mentioning small-bowel malignancy as 
found by capsule endoscopy [10]. The percentage of small-bowel tumors in the 892 patients recorded was 3.8%. 
In a recent published abstract, Schwartz & Barkin recorded 49 malignant tumors found using capsule endoscopy 
[11]. Some of these findings, however, were located in endoscopically accessible parts of the digestive tract, so 
that the added diagnostic yield of capsule endoscopy is difficult to evaluate from the abstract. 
A large meta-analysis was presented at the Third International Conference on capsule endoscopy in Miami, 
Florida, USA (B.Lewis). In this study, 9% of occult gastrointestinal bleedings were due to small-bowel tumors. 
We have no clear explanation for the differences observed in the various studies (2.5% in our study, 3.8% in the 
series of De Franchis et al., and 9% in the study of Lewis). The retrospective design of the studies, the fact that 
Lewis considers only patients with occult bleeding, and the variable place of capsule endoscopy in local 
algorithms could influence the results. 
In this Belgian multicenter study, we exclusively took small-bowel malignancies into account, because most 
findings of polyps or nodules (we found lesions described as polyps in seven patients and lesions described as 
nodules in three) were considered to be incidental and to have no impact on therapy. However, we cannot 
exclude that some of these lesions, while considered to be asymptomatic, could be small carcinoids or GIST 
tumors, or lymphomas. There are no data available in the literature on this point, and we need more information 
on the follow-up of these lesions in large studies. 
We found that the diagnostic yield of capsule endoscopy after a classical work-up had been performed was 1.6%. 
This percentage is low, but the disease is very uncommon. The mean number of diagnostic procedures performed 
before capsule endoscopy was 3.6, including some repeated procedures. This number of procedures done before 
capsule endoscopy is interestingly small, because in Belgium there is no reimbursement for capsule endoscopy, 
which is much more expensive than endoscopic or radiological procedures. In these circumstances, one could 
indeed expect that classical work-up before capsule endoscopy, especially in cases of bleeding of iron-deficiency 
anemia, would systematically include esophagogastroduodenoscopy, push enteroscopy, ileocolonoscopy, CT 
scan, and small-bowel radiography. In our series, only four push enteroscopies and four CT scans were 
performed before capsule endoscopy. In one case, a CT scan could afterwards identify the lesion found by 
capsule endoscopy. In patient 1, the tumor was located at the proximal jejunum and could probably have been 
detected by push enteroscopy. 
There is certainly a need to establish an algorithm for the diagnosis of small-bowel malignancies. Moreover, this 
algorithm will be influenced by local circumstances, such as the costs inherent to endoscopies and radiology 
procedures, and also whether or not capsule endoscopy is reimbursed. The most frequent clinical presentation of 
small-bowel tumors discovered by capsule endoscopy in this study and others was bleeding of undefined origin 
and iron-deficiency anemia. In accordance with other authors [12,13], and because of the diagnostic and 
therapeutic impact of capsule endoscopy in tumors, we could recommend the performance of capsule endoscopy 
after a classical endoscopic work-up (esophagogastroduodenoscopy, push enteroscopy if available, and 
ileocolonoscopy). 
Interestingly, 36% (4/11) of our patients presented other symptoms. The place of capsule endoscopy, especially 
for the indication of protein-losing enteropathy, needs further study. In any case, small-bowel malignancy is 
infrequent, accounting only for 2.5% of findings from a total of 443 capsule endoscopy procedures. Larger 
prospective studies are still needed to better define the rule and the timing of capsule endoscopy in small-bowel 
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diseases, especially malignant processes. 
In Brief 
A retrospective case collection of 11 small-bowel malignancies revealed in 443 capsule endoscopies. The four 
patients with adenocarcinoma all underwent capsule endoscopy because of iron deficiency anemia, the patients 
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